Biomedical Engineering Reference
In-Depth Information
Damoiseaux R, George S, Li M, Pokhrel S, Ji Z, France B, Xia T, Suarez E, Rallo R, Mädler
L, Cohen Y, Hoek EMV, Nel AE. (2011). No time to lose—high throughput screening to
assess nanomaterial safety.
Nanoscale
3:1345-1360.
Dan M, Wu P, Grulke EA, Graham UM, Unrine JM, Yokel RA. (2012). Ceria engineered nano-
material distribution in and clearance from blood: size matters.
Nanomed
7:95-110.
ECHA. (2008). Guidance on information requirements and chemical safety assessment.
Chapter R.6. QSARs and grouping of chemicals. European Chemicals Agency. 134 pp.;
availableat:http://echa.europa.eu/documents/10162/13632/information_requirements_
r6_en.pdf.
ECHA. (2010). Practical guide 4: How to report data waiving. European Chemicals Agency
ECHA-10-B-09-EN, 24 March 2010. 19 pp.; available at: http://echa.europa.eu/
documents/10162/13655/pg_report_data_waiving_en.pdf.
ECHA. (2012a). Guidance on information requirements and chemical safety assessment. Appendix
R7-1 Recommendations for nanomaterials applicable to Chapter R7a Endpoint specific
guidance. European Chemicals Agency ECHA-12-G-03-EN, April 2012. 60 pp.; available
at:http://echa.europa.eu/documents/10162/13632/appendix_r7a_nanomaterials_en.pdf.
ECHA. (2012b). Background Paper. An introduction to the assessment of read across. European
Chemicals Agency. 8pp.; available at:http://echa.europa.eu/documents/10162/5649897/
ws_raa_20121003_background_paper_an_introduction_to_the_assessment_of_read-
across_in_echa_en.pdf.
ECHA. (2012c). Assessment of read-across in REACH. European Chemicals Agency. 58pp.;
available at:http://echa.europa.eu/documents/10162/5649897/ws_raa_20121003_assess-
ment_of_read-across_in_echa_de_ raat_en.pdf.
ECHA. (2013). Grouping of substances and read-across approach. Part I. Introductory note.
European Chemicals Agency ECHA-13-R-02-EN. 11 pp.; availableat:http://echa.
europa.eu/documents/10162/13628/read_across_introductory_note_en.pdf.
Gasser M, Rothen-Rutishauser B, Krug HF, Gehr P, Nelle M, Yan B, Wick P. (2010). Lipids of
the pulmonary surfactant and functional groups on multi-walled carbon nanotubes influ-
ence blood plasma proteins adsorption differently.
J Nanobiotech
8:31.
Gasser M, Wick P, Clift MJ, Blank F, Diener L, Yan B, Gehr P, Krug HF, Rothen-Rutishauser
B. (2012). Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs)
influences their oxidative and pro-inflammatory potential in vitro.
Part Fibre Toxicol
9:17.
George S, Xia T, Rallo R, Zhao Y, Ji Z, Lin S, Wang X, Zhang H, France B, Schoenfeld D,
Damoiseaux R, Liu R, Lin S, Bradley KA, Cohen Y, Nel AE. (2011). Use of a high-
throughput screening approach coupled with in vivo zebrafish embryo screening to
develop hazard ranking for engineered nanomaterials.
ACS nano
5:1805-1817.
German Competent Authorities, (2011). Nanomaterials and REACH. Background paper on
the position of German competent authorities. 52 pages; availableat:http://www.reach-
clp-helpdesk.de/de/Downloads/Hintergrundpapier%20Nano%20und%20REACH%20
engl.%20Version.pdf?__blob = publicationFile.
Hankin SM, Peters SAK, Poland CA, Foss Hansen S, Holmqvist J, Ross BL, Varet J, Aitken
RJ. (2011). Specific advice on fulfilling information requirements for nanomaterials
under REACH (RIP-oN 2)-final project peport. REACH-NANO consultation. RNC/
RIP-oN2/FPR/1/FINAL. 356 pp; available at: http://ec.europa.eu/environment/chemi-
cals/nanotech/pdf/report_ripon2.pdf.
Hassellov M, Readman J, Rabville J, Tiede K. (2008). Nanoparticle analysis and character-
ization methodologies in environmental risk assessment of engineered nanoparticles.
Ecotoxicol
17:344-361.
Hristozov DR, Gottardo S, Cinelli M, Isigonis P, Zabeo A, Critto A, Van Tongeren M, Tran L,
Marcomini A. (2013). Application of a quantitative weight of evidence approach for ranking
and prioritising occupational exposure scenarios for titanium dioxide and carbon nanoma-
terials.
Nanotoxicol
15 Jan 2013, epub ahead of print. doi:10.3109/17435390.2012.760013.
Search WWH ::
Custom Search